GlassScriptPhysician profile
Kailyn Johnson
NPI 1093556938
$3,326.69
in general payments reported to CMS, 2019-2025
19 companies · $2,357 in 2025
The $2,357 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $969 · 2025: $2,357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,199 · Education: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,198.71 |
| Education | $127.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $521.70 | 2024-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $418.78 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $405.91 | 2024-2025 | |
| Janssen Biotech, INC. | $338.41 | 2024-2025 | Tremfya |
| Abbvie INC. | $318.90 | 2024-2025 | |
| Genzyme Corporation | $242.77 | 2024-2025 | |
| Mayne Pharma Commercial LLC | $231.46 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $205.86 | 2024-2025 | Zoryve |
| Galderma Laboratories, L.P. | $149.91 | 2025 | Nemluvio |
| Ucb, INC. | $98.22 | 2025 | Bimzelx |
| Lilly USA, LLC | $75.71 | 2024-2025 | Taltz, Ebglyss |
| Almirall LLC | $66.25 | 2025 | Seysara, Klisyri |
| Mallinckrodt Hospital Products INC. | $61.96 | 2024 | Acthar |
| Incyte Corporation | $43.05 | 2024-2025 | Opzelura |
| Amgen INC. | $40.91 | 2025 | Otezla |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $36.88 | 2025 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.92 | 2025 | Siliq, Jublia, Cabtreo |
| E.R. Squibb & Sons, L.L.C. | $23.46 | 2025 | Sotyktu |
| Leo Pharma INC. | $21.63 | 2025 | Anzupgo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kailyn Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.